Mantle Irradiation for Selected Hodgkin's Disease Patients With Stage IA-IIA Disease
- Eligble patients will receive a course of radiation therapy directed to above the
- Patients would have bloodwork and chest x-rays performed 4 times per year for the first
two years, 3 times per year for the third year, and 2 times per year for the fourth and
fifth years. After five years, yearly check-ups are performed.
- In addition to the above follow-up, patients will receive, once or twice a year for the
first 5 years, an abdominal-pelvic CT scan and/or gallium scan.
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
To evaluate the risks and benefits of mantle field irradiation alone in treating Hodgkin disease patients.
Peter Mauch, MD
Dana-Farber Cancer Institute
United States: Institutional Review Board
|Massachusetts General Hospital||Boston, Massachusetts 02114-2617|
|Dana-Farber Cancer Center||Boston, Massachusetts 02115|